(Q47594322)

English

Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15147353

Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin (English)

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15147353

0 references

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

author name string

Torre F

1

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15147353

Rossol S

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15147353

Pelli N

3

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15147353

Basso M

4

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15147353

Delfino A

5

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15147353

Picciotto A

6

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15147353

publication date

1 June 2004

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15147353

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15147353

136

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15147353

3

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15147353

507-512

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15147353

Hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Cytokines as a link between innate and adaptive antitumor immunity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Clearance kinetics of hepatitis C virus under different antiviral therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Two TNF receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

The dual role of IL-10.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Cytokine gene polymorphism in human disease: on-line databases, supplement 1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite proliferation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Lower th-1/th-2 ratio before interferon therapy may favor long-term virological responses in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Interleukin-12 p40/p70 ratio and in vivo responsiveness to IFN-alpha treatment in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Kinetics of the immune response during HBV and HCV infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Determinants of viral clearance and persistence during acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Hepatitis C virus infection: when silence is deception.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Pro- versus anti-inflammatory cytokines: myth or reality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809041

29 September 2018

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809041

29 September 2018

Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809041

29 September 2018

Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809041

29 September 2018

Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809041

29 September 2018

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809041

29 September 2018

Amantadine in Parkinson's disease: lymphocyte subsets and IL-2 secreting T cell precursor frequencies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

IL-10 and TNF-α polymorphisms and the recovery from HCV infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02476.X

21 January 2018

Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amantadine: a different approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon production in patients infected with HIV-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2249.2004.02476.X

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15147353

0 references

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/15147353

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47594322&oldid=2161205597"